Oncopeptides Announces First Patient Enrollment In Clinical "Window-Of-Opportunity" Study Evaluating Proprietary Peptide Drug Conjugate Platform In Glioblastoma

뉴스 본문을 불러오고 있어요.

Oncopeptides Announces First Patient Enrollment In Clinical "Window-Of-Opportunity" Study Evaluating Proprietary Peptide Drug Conjugate Platform In Glioblastoma | 웨이프 WAPE

Oncopeptides Announces First Patient Enrollment In Clinical "Window-Of-Opportunity" Study Evaluating Proprietary Peptide Drug Conjugate Platform In Glioblastoma

기사 요약

관련 종목

댓글 —